ValiRx PLC (VAL)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.70p

Buy

0.75p

arrow-down-0.025p (-3.33%)

Prices updated at 09 Jan 2025, 16:29 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
ValiRx PLC is a biopharmaceutical company. It is engaged in developing technologies and products in oncology therapeutics and diagnostics focused on the treatment of cancer and associated Biomarkers, specializing in epigenomic and genetic analysis.
FTSE All-Share
arrow-up0.75%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
0.78p - 0.69p
5.80p - 0.61p
-
2.81m
-
30,000
17,783,415
0.73
2,359,719.95
-1.19
102.32m
GB00BLH13C52
-0.02
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.